Lista de obras -

Anthrax Vaccine Precipitated induces Edema Toxin-neutralizing, Edema Factor-specific antibodies in human recipients

artículo científico publicado en 2017

BNT162b2 Vaccination in People Over 80 Years of Age Induces Strong Humoral Immune Responses with Cross Neutralisation of P.1 Brazilian Variant

artículo científico publicado en 2021

Bacillus anthracis: balancing innocent research with dual-use potential

artículo científico publicado en 2008

COVID-19: Rapid antigen detection for SARS-CoV-2 by lateral flow assay: A national systematic evaluation of sensitivity and specificity for mass-testing

artículo científico publicado en 2021

Cloned Defective Interfering Influenza Virus Protects Ferrets from Pandemic 2009 Influenza A Virus and Allows Protective Immunity to Be Established ⬇️

artículo científico publicado el 12 de diciembre de 2012

Comparison of rhesus and cynomolgus macaques as an infection model for COVID-19

artículo científico publicado en 2021

Comparison of the protection of ferrets against pandemic 2009 influenza A virus (H1N1) by 244 DI influenza virus and oseltamivir ⬇️

artículo científico publicado el 4 de octubre de 2012

Differential immunogenicity of BNT162b2 or ChAdOx1 vaccines after extended-interval homologous dual vaccination in older people

artículo científico publicado en 2021

Dose-dependent response to infection with SARS-CoV-2 in the ferret model and evidence of protective immunity

artículo científico publicado en 2021

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial

artículo científico publicado en 2021

Estimation of ELISA results using a parallel curve analysis

scientific article published on 19 August 2020

Evaluation of anthrax vaccine production by Bacillus anthracis Sterne 34F2 in stirred suspension culture using a miniature bioreactor: A useful scale-down tool for studies on fermentations at high containment

article

Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine induced sera

artículo científico publicado en 2021

Extended interval BNT162b2 vaccination enhances peak antibody generation

artículo científico publicado en 2022

Immunogenicity of single vaccination with BNT162b2 or ChAdOx1 nCoV-19 at 5–6 weeks post vaccine in participants aged 80 years or older: an exploratory analysis

scientific article published in 2021

Influenza A Virus Challenge Models in Cynomolgus Macaques Using the Authentic Inhaled Aerosol and Intra-Nasal Routes of Infection

artículo científico publicado en 2016

Interchangeability of meningococcal group C conjugate vaccines with different carrier proteins in the United Kingdom infant immunisation schedule

article

Lethal factor antibodies contribute to lethal toxin neutralization in recipients of anthrax vaccine precipitated

artículo científico publicado en 2017

Low dose influenza virus challenge in the ferret leads to increased virus shedding and greater sensitivity to oseltamivir.

artículo científico publicado en 2014

Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses

artículo científico publicado en 2020

Randomized Trial to Compare the Immunogenicity and Safety of a CRM or TT Conjugated Quadrivalent Meningococcal Vaccine in Teenagers who Received a CRM or TT Conjugated Serogroup C Vaccine at Preschool Age.

artículo científico publicado en 2015

Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera

artículo científico publicado en 2021

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial

artículo científico publicado en 2020

Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial

artículo científico publicado en 2021

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

scientific article published on 20 July 2020

Whole genome protein microarrays for serum profiling of immunodominant antigens of Bacillus anthracis

artículo científico publicado en 2015

mRNA vaccination in people over 80 years of age induces strong humoral immune responses against SARS-CoV-2 with cross neutralization of P.1 Brazilian variant

artículo científico publicado en 2021

Respuestas de anticuerpos después de la inmunización primaria en bebés nacidos de mujeres que reciben una vacuna que contiene tos ferina durante el embarazo: estudio observacional de un solo brazo con un comparador histórico.

artículo científico publicado en 2015

Lista de obras de

Anthrax Vaccine Precipitated induces Edema Toxin-neutralizing, Edema Factor-specific antibodies in human recipients

BNT162b2 Vaccination in People Over 80 Years of Age Induces Strong Humoral Immune Responses with Cross Neutralisation of P.1 Brazilian Variant

Bacillus anthracis: balancing innocent research with dual-use potential

COVID-19: Rapid antigen detection for SARS-CoV-2 by lateral flow assay: A national systematic evaluation of sensitivity and specificity for mass-testing

Cloned Defective Interfering Influenza Virus Protects Ferrets from Pandemic 2009 Influenza A Virus and Allows Protective Immunity to Be Established ⬇️

Comparison of rhesus and cynomolgus macaques as an infection model for COVID-19

Comparison of the protection of ferrets against pandemic 2009 influenza A virus (H1N1) by 244 DI influenza virus and oseltamivir ⬇️

Differential immunogenicity of BNT162b2 or ChAdOx1 vaccines after extended-interval homologous dual vaccination in older people

Dose-dependent response to infection with SARS-CoV-2 in the ferret model and evidence of protective immunity

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial

Estimation of ELISA results using a parallel curve analysis

Evaluation of anthrax vaccine production by Bacillus anthracis Sterne 34F2 in stirred suspension culture using a miniature bioreactor: A useful scale-down tool for studies on fermentations at high containment

Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine induced sera

Extended interval BNT162b2 vaccination enhances peak antibody generation

Immunogenicity of single vaccination with BNT162b2 or ChAdOx1 nCoV-19 at 5–6 weeks post vaccine in participants aged 80 years or older: an exploratory analysis

Influenza A Virus Challenge Models in Cynomolgus Macaques Using the Authentic Inhaled Aerosol and Intra-Nasal Routes of Infection

Interchangeability of meningococcal group C conjugate vaccines with different carrier proteins in the United Kingdom infant immunisation schedule

Lethal factor antibodies contribute to lethal toxin neutralization in recipients of anthrax vaccine precipitated

Low dose influenza virus challenge in the ferret leads to increased virus shedding and greater sensitivity to oseltamivir.

Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses

Randomized Trial to Compare the Immunogenicity and Safety of a CRM or TT Conjugated Quadrivalent Meningococcal Vaccine in Teenagers who Received a CRM or TT Conjugated Serogroup C Vaccine at Preschool Age.

Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial

Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

Whole genome protein microarrays for serum profiling of immunodominant antigens of Bacillus anthracis

mRNA vaccination in people over 80 years of age induces strong humoral immune responses against SARS-CoV-2 with cross neutralization of P.1 Brazilian variant

Respuestas de anticuerpos después de la inmunización primaria en bebés nacidos de mujeres que reciben una vacuna que contiene tos ferina durante el embarazo: estudio observacional de un solo brazo con un comparador histórico.